Press Releases

Softgel Capsules Market to Reach US$ 12.1 Bn by 2030

Share This Article

The global Softgel Capsules market size is estimated to be valued at US$ 12.1 billion in 2030, and is expected to exhibit a CAGR of 11.0% over the forecast period (2021-2030).

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38680

Growth Factors

 Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance.

Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as softgel capsule segment registers nearly 40.0% of their overall revenue

Report Coverage

Report Scope Details
Market Size USD 12.1 billion by 2030
Growth Rate CAGR of 11.0% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Application, Manufacturer
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Fuji Capsules Co Ltd.; Sirio Pharma; Captek; Patheon; Catalent; Eurocaps; Aenova; Capsugel; Procaps Laboratories; Soft gel Technologies Inc.

Growth Factors

By Application Analysis

The vitamins and dietary supplements segment dominated the market and accounted for the largest revenue share of 26.1% in 2020. Vitamins are prone to atmospheric oxidation and degradation when formulated as tablets or gummies. Hence, softgel capsules are the best formulation choice, as it protects for from UV radiation and oxidation ultimately improving its shelf life.

Health supplements held the second position in the application segment due to increased adoption of healthy lifestyles among masses to tackle the pandemic. Wide acceptance of pre- and post-natal capsules, and inclination towards tasteless medication, led to the increase in sales of softgel capsules, enhancing pregnancy market growth.

By Manufacturer Analysis

The nutraceutical segment accounted for the largest share of 37.6% in 2020. Nutraceutical companies mainly focus on developing vitamins, minerals, and health supplements. Thus, softgel formulation is largely developed to keep up the rising need for nutraceutical products.

The formulations segment accounted for nearly 31% of the total revenue of most nutraceutical manufacturers. Increasing awareness of health supplements among developing nations, a growing number of production houses, and surge in sales due to the COVID-19 pandemic, has led to its high growth and large market share.

By Type Analysis

The gelatin-based/ animal-based segment dominated the market accounted for the largest share of 72.8% in 2020. Over 80 years, gelatin is the choicest excipient of manufacturers due to its unparallel advantages over any other excipient. Ease of digestion, tamper-evident capsule production, superior mechanical resistance and seal quality, patient compliant, abundant resource availability, inert, and clean label raw material, are the factors responsible for its wide acceptance in the market.

Now-a-days, manufacturers are developing capsules using a combination of bovine and porcine gelatin due to their unique properties. Gelatin extracted from bovine enhanced capsule firmness and that from porcine provides plasticity and clarity characteristics to the formulation.

By Regional Analysis

North America dominated the market and accounted for the largest revenue share of 29.1% in 2020. Improved production technology, presence of major players within the region, and increased expenditure on R&D to widen their product portfolio.

The enormous presence of generic medicine manufacturers in China and India, increasing demand for cost-efficient therapeutics, rapidly growing economical conditions, and rise in contract manufacturing organizations within the region, are factors responsible for its high growth.

Key Players

  • Fuji Capsules Co Ltd
  • Sirio Pharma
  • Captek
  • Patheon
  • Catalent
  • Eurocaps
  • Aenova
  • Capsugel
  • Procaps Laboratories
  • Soft gel Technologies Inc.

Market Segmentation

  • Type
    • Gelatin-based/Animal-based
    • Non-animal-based
  • Application
    • Antacid and anti-flatulent preparations
    • Anti-anemic preparations
    • Anti-inflammatory drugs
    • Antibiotic and antibacterial drugs
    • Cough and cold preparations
    • Health supplement
    • Vitamin and dietary supplement
    • Pregnancy
  • Manufacturers
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Cosmeceutical Companies
    • Contract Manufacturing Organization
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Norway
      • Sweden
      • Russia
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Thailand
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • Turkey
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38680

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Softgel Capsules Market, By Type

7.1.  Softgel Capsules Market, by Type, 2021-2030

7.1.1.    Gelatin-based/Animal-based

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Non-animal-based

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Softgel Capsules Market, By Application

8.1.  Softgel Capsules Market, by Application, 2021-2030

8.1.1.    Antacid and anti-flatulent preparations

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Anti-anemic preparations

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Anti-inflammatory drugs

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Antibiotic and antibacterial drugs

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Cough and cold preparations

8.1.5.1.        Market Revenue and Forecast (2017-2030)

8.1.6.    Health supplement

8.1.6.1.        Market Revenue and Forecast (2017-2030)

8.1.7.    Vitamin and dietary supplement

8.1.7.1.        Market Revenue and Forecast (2017-2030)

8.1.8.    Pregnancy

8.1.8.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Softgel Capsules Market, By Manufacturers

9.1.  Softgel Capsules Market, by Manufacturers, 2021-2030

9.1.1.    Pharmaceutical Companies

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Nutraceutical Companies

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Cosmeceutical Companies

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Contract Manufacturing Organization

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Softgel Capsules Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Type (2017-2030)

10.1.2.  Market Revenue and Forecast, by Application (2017-2030)

10.1.3.  Market Revenue and Forecast, by Manufacturers (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Type (2017-2030)

10.2.2.  Market Revenue and Forecast, by Application (2017-2030)

10.2.3.  Market Revenue and Forecast, by Manufacturers (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Type (2017-2030)

10.3.2.  Market Revenue and Forecast, by Application (2017-2030)

10.3.3.  Market Revenue and Forecast, by Manufacturers (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Type (2017-2030)

10.4.2.  Market Revenue and Forecast, by Application (2017-2030)

10.4.3.  Market Revenue and Forecast, by Manufacturers (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Type (2017-2030)

10.5.2.  Market Revenue and Forecast, by Application (2017-2030)

10.5.3.  Market Revenue and Forecast, by Manufacturers (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Manufacturers (2017-2030)

Chapter 11.  Company Profiles

11.1.              Fuji Capsules Co Ltd

11.1.1.  Company Overview

11.1.2.  Type Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Sirio Pharma

11.2.1.  Company Overview

11.2.2.  Type Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Captek

11.3.1.  Company Overview

11.3.2.  Type Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Patheon

11.4.1.  Company Overview

11.4.2.  Type Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Catalent

11.5.1.  Company Overview

11.5.2.  Type Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Eurocaps

11.6.1.  Company Overview

11.6.2.  Type Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Aenova

11.7.1.  Company Overview

11.7.2.  Type Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Capsugel

11.8.1.  Company Overview

11.8.2.  Type Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Procaps Laboratories

11.9.1.  Company Overview

11.9.2.  Type Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Soft gel Technologies Inc.

11.10.1.               Company Overview

11.10.2.               Type Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38680

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

 

Related Articles

Back to top button